Immunisation Community of Practice

Share Immunisation Community of Practice on Facebook Share Immunisation Community of Practice on Twitter Share Immunisation Community of Practice on Linkedin Email Immunisation Community of Practice link

Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.

The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).

Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.

Some of the benefits of joining this Community are:

  • 24/7 access to filed Immunisation resources,
  • keep current with Immunisation updates,
  • brainstorm about Immunisation,
  • and network with colleagues passionate about Immunisation.

Welcome to the Immunisation Community of Practice. A community of practice (CoP) is a group of people with a shared passion who come together and learn how to do better. The PHNs Immunisation CoP is your opportunity to get answers, share ideas and build your professional network regarding immunisation.

The PHN Immunisation CoP aims to reduce the incidence of vaccine preventable diseases in the community by providing appropriate and timely information about vaccine preventable diseases and the Immunise Australia Program to immunisation providers and the community and promote the delivery of the National Immunisation Program (NIP).

Immunisation is a simple, safe and effective way of protecting people against harmful diseases that can cause serious health problems in the community. Immunisation not only protects individuals from life-threatening diseases, but also dramatically reduces transmission in the community. The more people who are vaccinated, the fewer opportunities a disease has to spread.

Some of the benefits of joining this Community are:

  • 24/7 access to filed Immunisation resources,
  • keep current with Immunisation updates,
  • brainstorm about Immunisation,
  • and network with colleagues passionate about Immunisation.
  • How to claim Flu Vaccine Reimbursement

    Share How to claim Flu Vaccine Reimbursement on Facebook Share How to claim Flu Vaccine Reimbursement on Twitter Share How to claim Flu Vaccine Reimbursement on Linkedin Email How to claim Flu Vaccine Reimbursement link

    How to claim:

    1. Complete the reimbursement form (one form per practice)
    2. Attach vaccine purchase invoice
    3. Email to: MOH-NSWHealth@health.nsw.gov.au (no confirmation email is sent)

    Deadline: COB Friday 26th August 2022

    Next steps:

    Approximately 1-2 weeks after your email has been sent, you will receive an additional email from NSW Health

    • From email HSNSW-eBusiness.WorkflowMailer@health.nsw.gov.au
    • Subject line:For Your Information: Invitation to register from Health System Support Group”
    • With a request to set up your practice as a vendor in the NSW Health system
    • Once you have been set up as a vendor, your payment request will be processed

    If you have any questions regarding this reimbursement process, please contact NSW Health MOH-NSWHealth@health.nsw.gov.au.

  • Pneumococcal pneumonia: Awareness campaign

    Share Pneumococcal pneumonia: Awareness campaign on Facebook Share Pneumococcal pneumonia: Awareness campaign on Twitter Share Pneumococcal pneumonia: Awareness campaign on Linkedin Email Pneumococcal pneumonia: Awareness campaign link
    supporting image

    Pfizer is sponsoring a 6-week consumer awareness radio campaign on pneumococcal pneumonia that will commence on 29th August 2022 on 2GB in Sydney and 3AW in Melbourne. This campaign is a pilot and may be extended to other cities later this year.

    There are 15 second and 30 second versions of two different ads, directing consumers to visit mylunghealth.com.au to take a short quiz to assess their risk of pneumococcal pneumonia and to speak to their doctor or nurse for more information.

    You can listen to the 30 second versions of the ads by clicking the links below.

    Since July 2020, one dose of Prevenar 13® is funded for non-Indigenous adults 70 years and older, Indigenous adults 50 years and older* and people with certain risk conditions*. Prevenar 13® can be given at any time of year and only one dose is needed.

    Prevenar 13® is recommended even in patients who have previously received 23vPPV, at least 12 months after their 23vPPV dose.

    Please visit the Australian Immunisation Handbook for a complete list of funded risk conditions and pneumococcal vaccine recommendations https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/pneumococcal-disease#recommendations

    *followed by 23vPPV doses

  • Virtual Coast to Country Immunisation Conference 2022: Share Your Story

    Share Virtual Coast to Country Immunisation Conference 2022: Share Your Story on Facebook Share Virtual Coast to Country Immunisation Conference 2022: Share Your Story on Twitter Share Virtual Coast to Country Immunisation Conference 2022: Share Your Story on Linkedin Email Virtual Coast to Country Immunisation Conference 2022: Share Your Story link

    Share Your Immunisation Story via a photo or video

    Are you interested in sharing your story via a pre-flimed video on how you have overcome or addressed an immunisation problem or have a great story to share?

    If so please email details of your story to Rebecca at rbrennan@thephn.com.au, by Friday September 2nd

  • Today is National Aboriginal and Torres Strait Islander Children’s Day

    Share Today is National Aboriginal and Torres Strait Islander Children’s Day on Facebook Share Today is National Aboriginal and Torres Strait Islander Children’s Day on Twitter Share Today is National Aboriginal and Torres Strait Islander Children’s Day on Linkedin Email Today is National Aboriginal and Torres Strait Islander Children’s Day link
    supporting image

    On this day I'd like to remind you that the meningococcal B vaccine (Bexsero®) was added to the National Immunisation Program schedule for Aboriginal and Torres Strait Islander children <2 years of age, on the 1 July 2020.

    Why is it being funded?

    The incidence of invasive meningococcal disease (IMD) caused by serogroup B is highest in young children compared with other age groups and it is about 4 times higher in Aboriginal and Torres Strait Islander children aged <2 years than in non-Indigenous children.

    Immunisation providers are reminded to identify Aboriginal and Torres Strait Islander people within your practices and discuss the need for additional recommended vaccines. It is important to alert parents of the need to buy paracetamol prior to vaccination.

    Dose schedule

    The number of Bexsero® doses required depends on age and presence of any medical conditions that increase the risk of IMD. For Aboriginal and Torres Strait Islander children with:

    • no medical risk conditions: 3 doses in total (given at 2*, 4 and 12 months of age)
    • with risk conditions for IMD:4 doses in total (given at 2*, 4, 6 and 12 months of age)

    Catch-up vaccination

    Meningococcal B vaccine catch-up is available for all Aboriginal and Torres Strait Islander children aged <2 years until 30 June 2023.

    Co-administration with other vaccines

    The meningococcal B vaccine (Bexsero®) can be safely administered with other childhood vaccines and can be given at the same time at the 2*, 4 and 12 months schedule points.

    Meningococcal vaccines for Australians - NCIRS fact sheet

    Clinical advice for vaccination providers - Meningococcal vaccination schedule from 1 July 2020

    Meningococcal B consumer resources

    • Order posters here
    • Order brochures here

    Hear from this year's Aboriginal and Torres Strait Islander Children's Day Ambassador Thomas Mayor about the 2022 theme and how to get involved: https://buff.ly/3oSOLLQ

  • NEW RESOURCE Co-administration of vaccines for adults: a guide for immunisation providers

    Share NEW RESOURCE Co-administration of vaccines for adults: a guide for immunisation providers on Facebook Share NEW RESOURCE Co-administration of vaccines for adults: a guide for immunisation providers on Twitter Share NEW RESOURCE Co-administration of vaccines for adults: a guide for immunisation providers on Linkedin Email NEW RESOURCE Co-administration of vaccines for adults: a guide for immunisation providers link

    Vaccines are recommended throughout an individual’s life to protect against vaccine-preventable diseases severity and complications. Increasingly more vaccines are becoming available and are recommended for use in adults. This guide aims to assist immunisation providers identify vaccines that can be co-administered in people aged 18 years and older.

    This guide should be used in conjunction with the Australian Immunisation Handbook and is available on the NCIRS website.

    Co-administration of vaccines for adults: a guide for immunisation providers

  • Flu Reimbursement Form now available

    Share Flu Reimbursement Form now available on Facebook Share Flu Reimbursement Form now available on Twitter Share Flu Reimbursement Form now available on Linkedin Email Flu Reimbursement Form now available link

    The Ministry of Health (MoH) have recently released information re the Reimbursement of private flu vaccines that were purchased for the “Free Flu Vaccine” in June/July program. Please contact your PCIO or myself if you did not receive this notification or require a copy of the form.

    Once the form is completed, all relevant invoices are to be attached and returned to to MOH-NSWHealth@health.nsw.gov.au by COB Friday 26 August 2022.

    The form states it is to be used by GPs. It has been clarified by the MoH, that one form should be submitted per practice, the person completing the form (who is listed as the contact person), should be the most appropriate person at the practice to assist with vendor set up. This person could be a practice manager, nurse or GP. One provider number can be listed even if that provider is not completing the form.

  • NSW Health advice: FluQuadri packaging

    Share NSW Health advice: FluQuadri packaging on Facebook Share NSW Health advice: FluQuadri packaging on Twitter Share NSW Health advice: FluQuadri packaging on Linkedin Email NSW Health advice: FluQuadri packaging link
    supporting image

    Sanofi have advised that some FluQuadri vaccine stock supplied into Australia has international packaging with eligibility wording “For 3 years of age and older” (see photo). This includes FluQuadri supplied for the NSW Government’s universal flu vaccine program for people aged 5-64 years, who are not otherwise eligible under the National Immunisation Program (NIP).

    The ATAGI statement of the administration of seasonal influenza vaccines in 2022 advises that FluQuadri may be given to children from 6 months of age.

    Sanofi advises that these batches were approved by the TGA for supply in Australia under s19A, and that Sanofi was required to send this advice to all GP practices before distributing.

    Provider reminder: ALL children aged 6 months to <5 years are eligible for free influenza vaccine under the NIP (Vaxigrip Tetra and Fluarix Tetra) as detailed in the ATAGI statement.

  • ATAGI updated recommendations for a winter dose of COVID-19 vaccine

    Share ATAGI updated recommendations for a winter dose of COVID-19 vaccine on Facebook Share ATAGI updated recommendations for a winter dose of COVID-19 vaccine on Twitter Share ATAGI updated recommendations for a winter dose of COVID-19 vaccine on Linkedin Email ATAGI updated recommendations for a winter dose of COVID-19 vaccine link
    supporting image
    ATAGI has updated its recommendations for a winter dose of COVID-19 vaccine.
    These are:
    • Adults aged 50 to 64 years are now recommended to receive a winter booster dose of a COVID-19 vaccine.
    • Adults aged 30 to 49 years can receive a winter booster dose of a COVID-19 vaccine, however the benefit for people in this age group is less certain.
    • The interval recommended between a recent SARS-CoV-2 infection or the first booster dose and a winter booster dose is now 3 months.
    People previously eligible for a winter booster dose are at a higher risk of severe disease and death from COVID-19 and should receive a winter booster dose as soon as possible. ATAGI advises that individuals previously infected with SARS-CoV-2, irrespective of the variant, should continue to receive recommended vaccine doses, after an interval of 3 months. This is because a previous infection will not provide sufficient protection against severe disease.
    The full detailed recommendations are available on the Department of Health and Aged Care website.
  • Zostavax supply issues

    Share Zostavax supply issues on Facebook Share Zostavax supply issues on Twitter Share Zostavax supply issues on Linkedin Email Zostavax supply issues link

    The following item is posted on the Vaccine Ordering Centre website:

    Zostavax remains restricted due to national supply shortages. To ensure ongoing supply to all immunisation providers, ordering quantities will be restricted until supply issues stabilise.

  • Reimbursement for privately funded influenza vaccines

    Share Reimbursement for privately funded influenza vaccines on Facebook Share Reimbursement for privately funded influenza vaccines on Twitter Share Reimbursement for privately funded influenza vaccines on Linkedin Email Reimbursement for privately funded influenza vaccines link
    CLOSED: This discussion has concluded.
    supporting image

    General practices who privately purchased flu vaccines for the NSW free flu vaccine in June/July” program, will be able to submit a declaration form at the conclusion of the program (17 July 2022) to seek remuneration for the purchase cost of quantities administered during 1 June to 17 July.

    Practices will need to complete one declaration form with attached invoices after 17 July 2022. The declaration form is still in development and will be circulated in July. As soon as the form becomes available, the PHN will update you.

    For now, practices should keep records of:

    1. invoices of privately purchased flu vaccines
    2. number of private flu vaccines administered during 1 June to 17 July
Page last updated: 07 Jun 2024, 02:19 PM